Dublin, May 07, 2019 (GLOBE NEWSWIRE) -- The "The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)" report has been added to ResearchAndMarkets.com's offering.

Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and, most recently, convenience clinics. This Worldwide Market for Point-of-Care (POC) Diagnostics takes a deep look at the POC diagnostic industry, part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine.

The global POC testing market is composed of two major categories: professional testing, which includes physician office labs, clinic labs, employer labs and hospital labs, and self-testing, which includes home, drug store testing and continuous glucose testing. The report presents market analysis by product categories, market analysis by subcategory, market analysis by device technology, market analysis by country (including the United States, Europe, Japan, and rest of world), and competitive analysis.

The following global market data are provided:

  • Global POC Test Market, 2016-2023
  • Global POC Testing Market Analysis by Product Category, 2018
  • Global POC Self-Testing Market Analysis by Product Category, 2018
  • Global POC Professional Testing Market Analysis by Product Subcategory, 2018
  • POC Testing by End-user, 2018
  • Global POC Market by Technology by Sales, 2018
  • US POC Testing Market Analysis, 2018-2023
  • Europe POC Testing Market Analysis, 2018-2023
  • Global POC Testing Market Analysis by European Region, 2018
  • Japan POC Testing Market Analysis, 2018-2023
  • Global POC Testing Market Analysis by Rest of World Region/Country, 2018
  • Global POC Testing Analysis by Region/Country, 2018

Segment Size and Growth

POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time more, decentralized test venues invest in non-waived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record.

Regional Analysis

Selected POC segments represent higher growth prospects for vendors and manufacturers due to clinical drivers in established POC markets (United States, Europe) and developing markets alike. Promising developments in emerging regions include the introduction and success of Western-style physician practices and multi-specialty clinics that perform many standard POC rapid tests.

Companies Mentioned

  • 1 Step Detect Associates, LLC
  • Abaxis, Inc.
  • Abbott Laboratories
  • Abingdon Health, Ltd.
  • AccessBio, Inc.
  • AccuBioTech Co, Ltd.
  • Accutech, LLC
  • Akers Biosciences, Inc.
  • Alere Acquisition Update
  • AmniSure International
  • Augurix Diagnostic
  • Axxin
  • Beckman Coulter, Inc
  • Becton Dickinson (BD)
  • Boditech Med Inc
  • Boson Biotech Co. Ltd
  • CARE , Inc.
  • Church & Dwight Co. Inc
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Daktari Diagnostics
  • Danaher Corporation
  • DRG International, Inc.
  • Eiken Chemical Co Ltd.
  • EKF Diagnostics Holdings plc
  • GenBio
  • Genedrive plc
  • GeTein BioMedical, Inc.
  • Helena Laboratories
  • Immunostics, Inc
  • InSilixa, Inc
  • Instrumentation Laboratory
  • JAL Innovation PTE LTD
  • LamdaGen Corporation
  • LifeScan, Inc
  • LifeSign, LLC
  • Magnasense Technologies
  • Mbio Diagnostics, Inc
  • Medix Biochemica
  • MedMira, Inc
  • Medtronic, Inc.
  • Menarini Diagnostics srl.
  • Meridian Bioscience, Inc
  • Micronics, Inc
  • Mitra & Co Pvt. Ltd
  • Nano-Ditech Corporation
  • Polymedco, Inc
  • QuantuMDx Group Limited
  • Quidel Corporation
  • Radiometer Medical A/S
  • Rheonix, Inc
  • Roche Diagnostic Corporation
  • Samsung Healthcare
  • Savyon Diagnostics
  • Trividia Health
  • Tulip Diagnostics Ltd
  • Veredus Laboratories PTE Ltd
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen

For more information about this report visit https://www.researchandmarkets.com/r/l1b7od

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health, Glucose Testing, Point-of-Care Diagnostics, Coagulation and Hemostasis Testing, Infectious Disease Testing, Cholesterol Testing, Maternal and Neonatal Care